Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusionvs. oral tablets

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

(2013) C Warren Olanow et al.   LANCET NEUROLOGY

Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results

(2013) Hubert H. Fernandez et al.   PARKINSONISM & RELATED DISORDERS

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

(2012) Dag Nyholm et al.   AAPS Journal

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson's Disease

(2011) Cuiping Chen et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Pharmacokinetics and pharmacodynamics of levodopa

(2008) John G. Nutt   MOVEMENT DISORDERS

Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness

(2008) Oleh Hornykiewicz   Neurodegenerative Diseases